Torrent Pharmaceuticals has reported results for its third quarter ended December 31, 2011.
The company has posted a 6.73% fall in net profit after tax of Rs 61.51 crore for the quarter ended December 31, 2011 as compared to Rs 65.95 crore for the same quarter in the previous year. Total income has increased by 13.96% from Rs 461.37 crore for Q3FY11 to Rs 525.78 crore in the quarter under review.
On the consolidated basis the group has posted a net profit rise of 8.15% to Rs 83.18 crore for the quarter ended December 31, 2011 as compared to Rs 76.91 crore in the same quarter last year. Total Income of the company improved by 20.64% to Rs 698.93 crore for the quarter compared to Rs 579.35 crore in the quarter, year ago.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: